pain of intramuscular injection.
Conditions
Interventions
Intervention 1: Intervention group: Selection of injection site using an algorithm extracted from demographic and anthropometric indices. Intervention 2: Intervention group: Selection injection site w
Sponsors
No funding
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Participants in the research have written consent There is no problem communicating (example: hearing, vision, speech, common language) At least 18 years old and maximum 65 years
Exclusion criteria
Exclusion criteria: Having very severe pain due to the disease Having a physical (motor or sensory) problem Toughness and tenderness and pain at the injection site Having a former injection site in the last two weeks Patients with psychopathy, diabetes,neuropathy, delirium, dementia, coagulopathy, and those had an extreme fear of injections Use of opiate or non-opiate analgesics 6 hours before enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of pain after intramuscular injection in gluteal muscles. Timepoint: After injection. Method of measurement: The Visual Analogue Scale (VAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzam Khosrojerdy
Sabzevar University of Medical Sciences
Outcome results
None listed